Cargando…

Drug susceptibility prediction against a panel of drugs using kernelized Bayesian multitask learning

Motivation: Human immunodeficiency virus (HIV) and cancer require personalized therapies owing to their inherent heterogeneous nature. For both diseases, large-scale pharmacogenomic screens of molecularly characterized samples have been generated with the hope of identifying genetic predictors of dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Gönen, Mehmet, Margolin, Adam A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147917/
https://www.ncbi.nlm.nih.gov/pubmed/25161247
http://dx.doi.org/10.1093/bioinformatics/btu464
_version_ 1782332537319718912
author Gönen, Mehmet
Margolin, Adam A.
author_facet Gönen, Mehmet
Margolin, Adam A.
author_sort Gönen, Mehmet
collection PubMed
description Motivation: Human immunodeficiency virus (HIV) and cancer require personalized therapies owing to their inherent heterogeneous nature. For both diseases, large-scale pharmacogenomic screens of molecularly characterized samples have been generated with the hope of identifying genetic predictors of drug susceptibility. Thus, computational algorithms capable of inferring robust predictors of drug responses from genomic information are of great practical importance. Most of the existing computational studies that consider drug susceptibility prediction against a panel of drugs formulate a separate learning problem for each drug, which cannot make use of commonalities between subsets of drugs. Results: In this study, we propose to solve the problem of drug susceptibility prediction against a panel of drugs in a multitask learning framework by formulating a novel Bayesian algorithm that combines kernel-based non-linear dimensionality reduction and binary classification (or regression). The main novelty of our method is the joint Bayesian formulation of projecting data points into a shared subspace and learning predictive models for all drugs in this subspace, which helps us to eliminate off-target effects and drug-specific experimental noise. Another novelty of our method is the ability of handling missing phenotype values owing to experimental conditions and quality control reasons. We demonstrate the performance of our algorithm via cross-validation experiments on two benchmark drug susceptibility datasets of HIV and cancer. Our method obtains statistically significantly better predictive performance on most of the drugs compared with baseline single-task algorithms that learn drug-specific models. These results show that predicting drug susceptibility against a panel of drugs simultaneously within a multitask learning framework improves overall predictive performance over single-task learning approaches. Availability and implementation: Our Matlab implementations for binary classification and regression are available at https://github.com/mehmetgonen/kbmtl. Contact: mehmet.gonen@sagebase.org Supplementary Information: Supplementary data are available at Bioinformatics online.
format Online
Article
Text
id pubmed-4147917
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-41479172014-09-02 Drug susceptibility prediction against a panel of drugs using kernelized Bayesian multitask learning Gönen, Mehmet Margolin, Adam A. Bioinformatics Eccb 2014 Proceedings Papers Committee Motivation: Human immunodeficiency virus (HIV) and cancer require personalized therapies owing to their inherent heterogeneous nature. For both diseases, large-scale pharmacogenomic screens of molecularly characterized samples have been generated with the hope of identifying genetic predictors of drug susceptibility. Thus, computational algorithms capable of inferring robust predictors of drug responses from genomic information are of great practical importance. Most of the existing computational studies that consider drug susceptibility prediction against a panel of drugs formulate a separate learning problem for each drug, which cannot make use of commonalities between subsets of drugs. Results: In this study, we propose to solve the problem of drug susceptibility prediction against a panel of drugs in a multitask learning framework by formulating a novel Bayesian algorithm that combines kernel-based non-linear dimensionality reduction and binary classification (or regression). The main novelty of our method is the joint Bayesian formulation of projecting data points into a shared subspace and learning predictive models for all drugs in this subspace, which helps us to eliminate off-target effects and drug-specific experimental noise. Another novelty of our method is the ability of handling missing phenotype values owing to experimental conditions and quality control reasons. We demonstrate the performance of our algorithm via cross-validation experiments on two benchmark drug susceptibility datasets of HIV and cancer. Our method obtains statistically significantly better predictive performance on most of the drugs compared with baseline single-task algorithms that learn drug-specific models. These results show that predicting drug susceptibility against a panel of drugs simultaneously within a multitask learning framework improves overall predictive performance over single-task learning approaches. Availability and implementation: Our Matlab implementations for binary classification and regression are available at https://github.com/mehmetgonen/kbmtl. Contact: mehmet.gonen@sagebase.org Supplementary Information: Supplementary data are available at Bioinformatics online. Oxford University Press 2014-09-01 2014-08-22 /pmc/articles/PMC4147917/ /pubmed/25161247 http://dx.doi.org/10.1093/bioinformatics/btu464 Text en © The Author 2014. Published by Oxford University Press. http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Eccb 2014 Proceedings Papers Committee
Gönen, Mehmet
Margolin, Adam A.
Drug susceptibility prediction against a panel of drugs using kernelized Bayesian multitask learning
title Drug susceptibility prediction against a panel of drugs using kernelized Bayesian multitask learning
title_full Drug susceptibility prediction against a panel of drugs using kernelized Bayesian multitask learning
title_fullStr Drug susceptibility prediction against a panel of drugs using kernelized Bayesian multitask learning
title_full_unstemmed Drug susceptibility prediction against a panel of drugs using kernelized Bayesian multitask learning
title_short Drug susceptibility prediction against a panel of drugs using kernelized Bayesian multitask learning
title_sort drug susceptibility prediction against a panel of drugs using kernelized bayesian multitask learning
topic Eccb 2014 Proceedings Papers Committee
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147917/
https://www.ncbi.nlm.nih.gov/pubmed/25161247
http://dx.doi.org/10.1093/bioinformatics/btu464
work_keys_str_mv AT gonenmehmet drugsusceptibilitypredictionagainstapanelofdrugsusingkernelizedbayesianmultitasklearning
AT margolinadama drugsusceptibilitypredictionagainstapanelofdrugsusingkernelizedbayesianmultitasklearning